Review
. 2015 Jun; 11(8):1901-9.
doi: 10.1080/21645515.2015.1049779.

In-situ tumor vaccination: Bringing the fight to the tumor

Robert H Pierce 1 Jean S Campbell  Sara I Pai  Joshua D Brody  Holbrook E K Kohrt  
Affiliations
  • PMID: 26055074
  •     82 References
  •     29 citations

Abstract

After decades of development in the shadow of traditional cancer treatment, immunotherapy has come into the spotlight. Treatment of metastatic tumors with monoclonal antibodies to T cell checkpoints like programed cell death 1 (PD-1) or its ligand, (PD-L1), have resulted in significant clinical responses across multiple tumor types. However, these therapies fail in the majority of patients with solid tumors, in particular those who lack PD1(+)CD8(+) tumor-infiltrating lymphocytes within their tumors. Intratumoral "in situ vaccination" approaches seek to enhance immunogenicity, generate tumor infiltrating lymophcytes (TIL) and drive a systemic anti-tumor immune response, directed against "unvaccinated," disseminated tumors. Given the emerging picture of intratumoral immunotherapy as safe and capable of delivering systemic efficacy, it is anticipated that these approaches will become integrated into future multi-modality therapy.

Keywords: adaptive resistance; immunotherapy; intratumoral; melanoma.

Immune cell-poor melanomas benefit from PD-1 blockade after targeted type I IFN activation.
Tobias Bald, Jennifer Landsberg, +11 authors, Thomas Tüting.
Cancer Discov, 2014 Mar 05; 4(6). PMID: 24589924
Highly Cited.
Innate immunity: impact on the adaptive immune response.
R Medzhitov, C A Janeway.
Curr Opin Immunol, 1997 Feb 01; 9(1). PMID: 9039775
Highly Cited. Review.
Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity.
G Trinchieri.
Annu Rev Immunol, 1995 Jan 01; 13. PMID: 7612223
Highly Cited. Review.
An updated overview of HPV-associated head and neck carcinomas.
Apostolos Zaravinos.
Oncotarget, 2014 Jun 28; 5(12). PMID: 24970795    Free PMC article.
Review.
Rationale for combined blockade of PD-1 and CTLA-4 in advanced head and neck squamous cell cancer—review of current data.
Mark S Swanson, Uttam K Sinha.
Oral Oncol, 2014 Dec 03; 51(1). PMID: 25459157
Review.
Intratumoral injection of IL-12 plasmid DNA--results of a phase I/IB clinical trial.
D M Mahvi, M B Henry, +6 authors, P Sondel.
Cancer Gene Ther, 2007 Jun 09; 14(8). PMID: 17557109
Effects of single-dose interleukin-12 exposure on interleukin-12-associated toxicity and interferon-gamma production.
J P Leonard, M L Sherman, +7 authors, J L Ryan.
Blood, 1997 Nov 05; 90(7). PMID: 9326219
Highly Cited.
Update on immune checkpoint inhibitors in lung cancer.
Benjamin C Creelan.
Cancer Control, 2013 Dec 21; 21(1). PMID: 24357746
Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma.
Adil I Daud, Ronald C DeConti, +8 authors, Richard Heller.
J Clin Oncol, 2008 Nov 26; 26(36). PMID: 19029422    Free PMC article.
Highly Cited.
Role of TAP-1 and/or TAP-2 antigen presentation defects in tumorigenicity of mouse melanoma.
Shefali Agrawal, Keith Reemtsma, +2 authors, Ned S Braunstein.
Cell Immunol, 2004 Jun 29; 228(2). PMID: 15219464
Intratumoral electroporation of IL-12 cDNA eradicates established melanomas by Trp2(180-188)-specific CD8+ CTLs in a perforin/granzyme-mediated and IFN-γ-dependent manner: application of Trp2(180-188) peptides.
Jeong-Im Sin, Jae-Bok Park, +4 authors, Esteban Celis.
Cancer Immunol Immunother, 2012 Mar 03; 61(10). PMID: 22382361
Dendritic cells and macrophages are required for Th1 development of CD4+ T cells from alpha beta TCR transgenic mice: IL-12 substitution for macrophages to stimulate IFN-gamma production is IFN-gamma-dependent.
S E Macatonia, C S Hsieh, K M Murphy, A O'Garra.
Int Immunol, 1993 Sep 01; 5(9). PMID: 7902129
Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy.
Lionel Apetoh, François Ghiringhelli, +25 authors, Laurence Zitvogel.
Nat Med, 2007 Aug 21; 13(9). PMID: 17704786
Highly Cited.
PD-1 blockade induces responses by inhibiting adaptive immune resistance.
Paul C Tumeh, Christina L Harview, +23 authors, Antoni Ribas.
Nature, 2014 Nov 28; 515(7528). PMID: 25428505    Free PMC article.
Highly Cited.
Tumor stress, cell death and the ensuing immune response.
E Ullrich, M Bonmort, +2 authors, L Zitvogel.
Cell Death Differ, 2007 Nov 10; 15(1). PMID: 17992190
Review.
CTLA-4 ligation blocks CD28-dependent T cell activation.
T L Walunas, C Y Bakker, J A Bluestone.
J Exp Med, 1996 Jun 01; 183(6). PMID: 8676075    Free PMC article.
Highly Cited.
The interaction between HMGB1 and TLR4 dictates the outcome of anticancer chemotherapy and radiotherapy.
Lionel Apetoh, François Ghiringhelli, +11 authors, Laurence Zitvogel.
Immunol Rev, 2007 Nov 06; 220. PMID: 17979839
Highly Cited. Review.
Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer.
Naiyer A Rizvi, Matthew D Hellmann, +21 authors, Timothy A Chan.
Science, 2015 Mar 15; 348(6230). PMID: 25765070    Free PMC article.
Highly Cited.
Phase I trial of intratumoral injection of an adenovirus encoding interleukin-12 for advanced digestive tumors.
Bruno Sangro, Guillermo Mazzolini, +14 authors, Jesus Prieto.
J Clin Oncol, 2004 Apr 16; 22(8). PMID: 15084613
Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy.
Eric A Reits, James W Hodge, +14 authors, Jacques J Neefjes.
J Exp Med, 2006 Apr 26; 203(5). PMID: 16636135    Free PMC article.
Highly Cited.
An obligate cell-intrinsic function for CD28 in Tregs.
Ruan Zhang, Alexandria Huynh, +3 authors, Laurence A Turka.
J Clin Invest, 2013 Jan 03; 123(2). PMID: 23281398    Free PMC article.
Highly Cited.
Radiation-induced IFN-gamma production within the tumor microenvironment influences antitumor immunity.
Amit A Lugade, Elizabeth W Sorensen, +3 authors, Edith M Lord.
J Immunol, 2008 Feb 23; 180(5). PMID: 18292536
Highly Cited.
Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation.
S Read, V Malmström, F Powrie.
J Exp Med, 2000 Jul 19; 192(2). PMID: 10899916    Free PMC article.
Highly Cited.
Interleukin-12 in anti-tumor immunity and immunotherapy.
Mario P Colombo, Giorgio Trinchieri.
Cytokine Growth Factor Rev, 2002 Mar 20; 13(2). PMID: 11900991
Highly Cited. Review.
Local radiation therapy of B16 melanoma tumors increases the generation of tumor antigen-specific effector cells that traffic to the tumor.
Amit A Lugade, James P Moran, +3 authors, Edith M Lord.
J Immunol, 2005 Jun 10; 174(12). PMID: 15944250
Highly Cited.
Increase of NKG2D ligands and sensitivity to NK cell-mediated cytotoxicity of tumor cells by heat shock and ionizing radiation.
Joo-Young Kim, Young-Ok Son, +6 authors, Chi-Dug Kang.
Exp Mol Med, 2006 Nov 03; 38(5). PMID: 17079863
Calreticulin exposure dictates the immunogenicity of cancer cell death.
Michel Obeid, Antoine Tesniere, +14 authors, Guido Kroemer.
Nat Med, 2006 Dec 26; 13(1). PMID: 17187072
Highly Cited.
IL-12 reverses cytokine and immune abnormalities in Sezary syndrome.
A H Rook, M Kubin, +7 authors, S R Lessin.
J Immunol, 1995 Feb 01; 154(3). PMID: 7822812
Interleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes.
G Trinchieri.
Blood, 1994 Dec 15; 84(12). PMID: 7994020
Highly Cited. Review.
Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated.
Sandra Demaria, Bruce Ng, +4 authors, Silvia C Formenti.
Int J Radiat Oncol Biol Phys, 2004 Feb 18; 58(3). PMID: 14967443
Highly Cited.
Combining radiotherapy and immunotherapy: a revived partnership.
Sandra Demaria, Nina Bhardwaj, William H McBride, Silvia C Formenti.
Int J Radiat Oncol Biol Phys, 2005 Oct 04; 63(3). PMID: 16199306    Free PMC article.
Highly Cited. Review.
Radiation-induced CXCL16 release by breast cancer cells attracts effector T cells.
Satoko Matsumura, Baomei Wang, +8 authors, Sandra Demaria.
J Immunol, 2008 Aug 21; 181(5). PMID: 18713980    Free PMC article.
Highly Cited.
T-cell regulation by CD28 and CTLA-4.
M L Alegre, K A Frauwirth, C B Thompson.
Nat Rev Immunol, 2002 Mar 22; 1(3). PMID: 11905831
Highly Cited. Review.
Interleukin-12/T cell stimulating factor, a cytokine with multiple effects on T helper type 1 (Th1) but not on Th2 cells.
T Germann, M K Gately, +6 authors, E Rüde.
Eur J Immunol, 1993 Aug 01; 23(8). PMID: 8102100
In situ vaccination with a TLR9 agonist induces systemic lymphoma regression: a phase I/II study.
Joshua D Brody, Weiyun Z Ai, +10 authors, Ronald Levy.
J Clin Oncol, 2010 Aug 11; 28(28). PMID: 20697067    Free PMC article.
Highly Cited.
Improved survival with ipilimumab in patients with metastatic melanoma.
F Stephen Hodi, Steven J O'Day, +26 authors, Walter J Urba.
N Engl J Med, 2010 Jun 08; 363(8). PMID: 20525992    Free PMC article.
Highly Cited.
Killing Mechanisms of Cytotoxic T Lymphocytes.
Peter Groscurth, Luis Filgueira.
News Physiol Sci, 2001 Jun 08; 13. PMID: 11390753
Fever therapy revisited.
U Hobohm.
Br J Cancer, 2005 Feb 09; 92(3). PMID: 15700041    Free PMC article.
Review.
Antitumor and antimetastatic activity of interleukin 12 against murine tumors.
M J Brunda, L Luistro, +5 authors, M K Gately.
J Exp Med, 1993 Oct 01; 178(4). PMID: 8104230    Free PMC article.
Highly Cited.
Radiation-induced immunogenic modulation of tumor enhances antigen processing and calreticulin exposure, resulting in enhanced T-cell killing.
Sofia R Gameiro, Momodou L Jammeh, +3 authors, James W Hodge.
Oncotarget, 2014 Feb 01; 5(2). PMID: 24480782    Free PMC article.
Highly Cited.
Ipilimumab plus dacarbazine for previously untreated metastatic melanoma.
Caroline Robert, Luc Thomas, +21 authors, Jedd D Wolchok.
N Engl J Med, 2011 Jun 07; 364(26). PMID: 21639810
Highly Cited.
The blockade of immune checkpoints in cancer immunotherapy.
Drew M Pardoll.
Nat Rev Cancer, 2012 Mar 23; 12(4). PMID: 22437870    Free PMC article.
Highly Cited. Review.
Lessons from Coley's Toxin.
Kangla Tsung, Jeffrey A Norton.
Surg Oncol, 2006 Jul 04; 15(1). PMID: 16814541
Review.
Interleukin-12 therapy of cutaneous T-cell lymphoma induces lesion regression and cytotoxic T-cell responses.
A H Rook, G S Wood, +8 authors, E C Vonderheid.
Blood, 1999 Jul 27; 94(3). PMID: 10419880
Up-regulation of PD-L1, IDO, and T(regs) in the melanoma tumor microenvironment is driven by CD8(+) T cells.
Stefani Spranger, Robbert M Spaapen, +4 authors, Thomas F Gajewski.
Sci Transl Med, 2013 Aug 30; 5(200). PMID: 23986400    Free PMC article.
Highly Cited.
Survival, durable tumor remission, and long-term safety in patients with advanced melanoma receiving nivolumab.
Suzanne L Topalian, Mario Sznol, +18 authors, F Stephen Hodi.
J Clin Oncol, 2014 Mar 05; 32(10). PMID: 24590637    Free PMC article.
Highly Cited.
T-bet(+) Treg cells undergo abortive Th1 cell differentiation due to impaired expression of IL-12 receptor β2.
Meghan A Koch, Kerri R Thomas, +3 authors, Daniel J Campbell.
Immunity, 2012 Sep 11; 37(3). PMID: 22960221    Free PMC article.
Highly Cited.
CTLA-4 can function as a negative regulator of T cell activation.
T L Walunas, D J Lenschow, +5 authors, J A Bluestone.
Immunity, 1994 Aug 01; 1(5). PMID: 7882171
Highly Cited.
Coley's toxins, tumor necrosis factor and cancer research: a historical perspective.
B Wiemann, C O Starnes.
Pharmacol Ther, 1994 Jan 01; 64(3). PMID: 7724661
Highly Cited. Review.
Fractionated but not single-dose radiotherapy induces an immune-mediated abscopal effect when combined with anti-CTLA-4 antibody.
M Zahidunnabi Dewan, Ashley E Galloway, +4 authors, Sandra Demaria.
Clin Cancer Res, 2009 Aug 27; 15(17). PMID: 19706802    Free PMC article.
Highly Cited.
MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer.
Thomas Powles, Joseph Paul Eder, +12 authors, Nicholas J Vogelzang.
Nature, 2014 Nov 28; 515(7528). PMID: 25428503
Highly Cited.
Neo-antigens predicted by tumor genome meta-analysis correlate with increased patient survival.
Scott D Brown, Rene L Warren, +4 authors, Robert A Holt.
Genome Res, 2014 May 02; 24(5). PMID: 24782321    Free PMC article.
Highly Cited.
Tumor exome analysis reveals neoantigen-specific T-cell reactivity in an ipilimumab-responsive melanoma.
Nienke van Rooij, Marit M van Buuren, +14 authors, Ton N Schumacher.
J Clin Oncol, 2013 Sep 18; 31(32). PMID: 24043743    Free PMC article.
Highly Cited.
Intratumoral injection of DNA encoding human interleukin 12 into patients with metastatic melanoma: clinical efficacy.
Lucie Heinzerling, Günter Burg, +6 authors, Karin Moelling.
Hum Gene Ther, 2005 Feb 11; 16(1). PMID: 15703487
T-cell-antigen recognition and the immunological synapse.
Johannes B Huppa, Mark M Davis.
Nat Rev Immunol, 2003 Dec 04; 3(12). PMID: 14647479
Highly Cited. Review.
Intratumoral immunotherapy: using the tumour against itself.
Marka R Crittenden, Uma Thanarajasingam, Richard G Vile, Michael J Gough.
Immunology, 2004 Dec 21; 114(1). PMID: 15606790    Free PMC article.
Review.
Efficacy and safety of ipilimumab monotherapy in patients with pretreated advanced melanoma: a multicenter single-arm phase II study.
S J O'Day, M Maio, +13 authors, J D Wolchok.
Ann Oncol, 2010 Feb 12; 21(8). PMID: 20147741
Highly Cited.
Enhancement of antitumor radiation efficacy and consistent induction of the abscopal effect in mice by ECI301, an active variant of macrophage inflammatory protein-1alpha.
Kenshiro Shiraishi, Yoshiro Ishiwata, +7 authors, Shiro Kanegasaki.
Clin Cancer Res, 2008 Feb 19; 14(4). PMID: 18281550
Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens.
Matthew M Gubin, Xiuli Zhang, +24 authors, Robert D Schreiber.
Nature, 2014 Nov 28; 515(7528). PMID: 25428507    Free PMC article.
Highly Cited.
Therapeutic effects of ablative radiation on local tumor require CD8+ T cells: changing strategies for cancer treatment.
Youjin Lee, Sogyong L Auh, +9 authors, Yang-Xin Fu.
Blood, 2009 Apr 08; 114(3). PMID: 19349616    Free PMC article.
Highly Cited.
Insufficient interleukin-12 signalling favours differentiation of human CD4(+) and CD8(+) T cells into GATA-3(+) and GATA-3(+) T-bet(+) subsets in humanized mice.
Eva Billerbeck, Rachael N Labitt, +5 authors, Alexander Ploss.
Immunology, 2014 Apr 29; 143(2). PMID: 24766459    Free PMC article.
Intratumoral immunization: a new paradigm for cancer therapy.
Aurélien Marabelle, Holbrook Kohrt, Christophe Caux, Ronald Levy.
Clin Cancer Res, 2014 Apr 03; 20(7). PMID: 24691639    Free PMC article.
Highly Cited.
Molecular characteristics of immunogenic cancer cell death.
A Tesniere, T Panaretakis, +4 authors, G Kroemer.
Cell Death Differ, 2007 Nov 17; 15(1). PMID: 18007663
Highly Cited. Review.
Cancer despite immunosurveillance: immunoselection and immunosubversion.
Laurence Zitvogel, Antoine Tesniere, Guido Kroemer.
Nat Rev Immunol, 2006 Sep 16; 6(10). PMID: 16977338
Highly Cited. Review.
Chronic inflammation that facilitates tumor progression creates local immune suppression by inducing indoleamine 2,3 dioxygenase.
Alexander J Muller, Madhav D Sharma, +9 authors, Andrew L Mellor.
Proc Natl Acad Sci U S A, 2008 Oct 28; 105(44). PMID: 18952840    Free PMC article.
Highly Cited.
In situ vaccination as a therapy for low-grade lymphoma.
Joshua Brody.
Clin Adv Hematol Oncol, 2015 Feb 14; 13(1). PMID: 25679970
Approaching the asymptote? Evolution and revolution in immunology.
C A Janeway.
Cold Spring Harb Symp Quant Biol, 1989 Jan 01; 54 Pt 1. PMID: 2700931
Highly Cited. Review.
Phase I evaluation of intravenous recombinant human interleukin 12 in patients with advanced malignancies.
M B Atkins, M J Robertson, +12 authors, M L Sherman.
Clin Cancer Res, 1997 Mar 01; 3(3). PMID: 9815699
Highly Cited.
Cytotoxic T lymphocytes: all roads lead to death.
Michele Barry, R Chris Bleackley.
Nat Rev Immunol, 2002 Jul 03; 2(6). PMID: 12093006
Highly Cited. Review.
Blockade of CTLA-4 on CD4+CD25+ regulatory T cells abrogates their function in vivo.
Simon Read, Rebecca Greenwald, +5 authors, Fiona Powrie.
J Immunol, 2006 Sep 20; 177(7). PMID: 16982872    Free PMC article.
Highly Cited.
IL-12 inhibits the TGF-β-dependent T cell developmental programs and skews the TGF-β-induced differentiation into a Th1-like direction.
Jana Prochazkova, Katerina Pokorna, Vladimir Holan.
Immunobiology, 2011 Sep 10; 217(1). PMID: 21903294
Positive regulatory role of IL-12 in macrophages and modulation by IFN-gamma.
U Grohmann, M L Belladonna, +5 authors, P Puccetti.
J Immunol, 2001 Jun 22; 167(1). PMID: 11418652
Evidence for a role of the PD-1:PD-L1 pathway in immune resistance of HPV-associated head and neck squamous cell carcinoma.
Sofia Lyford-Pike, Shiwen Peng, +12 authors, Sara I Pai.
Cancer Res, 2013 Jan 05; 73(6). PMID: 23288508    Free PMC article.
Highly Cited.
Type I interferons induced by radiation therapy mediate recruitment and effector function of CD8(+) T cells.
Joanne Y H Lim, Scott A Gerber, Shawn P Murphy, Edith M Lord.
Cancer Immunol Immunother, 2013 Dec 21; 63(3). PMID: 24357146    Free PMC article.
In situ vaccination against mycosis fungoides by intratumoral injection of a TLR9 agonist combined with radiation: a phase 1/2 study.
Youn H Kim, Dita Gratzinger, +13 authors, Ronald Levy.
Blood, 2011 Nov 03; 119(2). PMID: 22045986    Free PMC article.
Therapeutic in situ autovaccination against solid cancers with intratumoral poly-ICLC: case report, hypothesis, and clinical trial.
Andres M Salazar, Rodrigo B Erlich, +2 authors, Ronald B Herberman.
Cancer Immunol Res, 2014 May 08; 2(8). PMID: 24801836
STING-Dependent Cytosolic DNA Sensing Promotes Radiation-Induced Type I Interferon-Dependent Antitumor Immunity in Immunogenic Tumors.
Liufu Deng, Hua Liang, +12 authors, Ralph R Weichselbaum.
Immunity, 2014 Dec 18; 41(5). PMID: 25517616    Free PMC article.
Highly Cited.
Cancer immunotherapy comes of age.
Ira Mellman, George Coukos, Glenn Dranoff.
Nature, 2011 Dec 24; 480(7378). PMID: 22193102    Free PMC article.
Highly Cited. Review.
Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti-CTLA-4 therapy against melanoma.
Tyler R Simpson, Fubin Li, +11 authors, Sergio A Quezada.
J Exp Med, 2013 Jul 31; 210(9). PMID: 23897981    Free PMC article.
Highly Cited.
Depleting tumor-specific Tregs at a single site eradicates disseminated tumors.
Aurélien Marabelle, Holbrook Kohrt, +13 authors, Ronald Levy.
J Clin Invest, 2013 Jun 04; 123(6). PMID: 23728179    Free PMC article.
Highly Cited.
Poor immunogenicity of a self/tumor antigen derives from peptide-MHC-I instability and is independent of tolerance.
Zhiya Yu, Marc R Theoret, +6 authors, Nicholas P Restifo.
J Clin Invest, 2004 Aug 18; 114(4). PMID: 15314692    Free PMC article.
Gene therapy of cancer with interleukin-12.
Guillermo Mazzolini, Jesús Prieto, Ignacio Melero.
Curr Pharm Des, 2003 Jul 23; 9(24). PMID: 12871184
DNA vaccines 2014 meeting: Highlights and overview.
Kenneth E Ugen, David B Weiner.
Hum Vaccin Immunother, 2015 Jul 15; 11(8). PMID: 26158530    Free PMC article.
The Cytolytic Amphipathic β(2,2)-Amino Acid LTX-401 Induces DAMP Release in Melanoma Cells and Causes Complete Regression of B16 Melanoma.
Liv-Marie Eike, Brynjar Mauseth, +2 authors, Baldur Sveinbjørnsson.
PLoS One, 2016 Feb 18; 11(2). PMID: 26881822    Free PMC article.
Oncolytic Viruses: Therapeutics With an Identity Crisis.
Caroline J Breitbach, Brian D Lichty, John C Bell.
EBioMedicine, 2016 Jul 14; 9. PMID: 27407036    Free PMC article.
Review.
Tumor-directed immunotherapy can generate tumor-specific T cell responses through localized co-stimulation.
Peter Ellmark, Sara M Mangsbo, +2 authors, Thomas H Tötterman.
Cancer Immunol Immunother, 2016 Oct 08; 66(1). PMID: 27714433    Free PMC article.
Review.
Improved survival and complete response rates in patients with advanced melanoma treated with concurrent ipilimumab and radiotherapy versus ipilimumab alone.
Kristian M Koller, Heath B Mackley, +9 authors, Joseph J Drabick.
Cancer Biol Ther, 2016 Dec 03; 18(1). PMID: 27905824    Free PMC article.
Intratumoral Immunization by p19Arf and Interferon-β Gene Transfer in a Heterotopic Mouse Model of Lung Carcinoma.
João Paulo Portela Catani, Ruan F V Medrano, +6 authors, Bryan E Strauss.
Transl Oncol, 2016 Dec 06; 9(6). PMID: 27916291    Free PMC article.
Combination of Plant Virus Nanoparticle-Based in Situ Vaccination with Chemotherapy Potentiates Antitumor Response.
Karin L Lee, Abner A Murray, +5 authors, Nicole F Steinmetz.
Nano Lett, 2017 Jun 27; 17(7). PMID: 28650644    Free PMC article.
Phase 1 study of intravenous administration of the chimeric adenovirus enadenotucirev in patients undergoing primary tumor resection.
Rocio Garcia-Carbonero, Ramon Salazar, +11 authors, Kerry Fisher.
J Immunother Cancer, 2017 Sep 20; 5(1). PMID: 28923104    Free PMC article.
Using immunotherapy to boost the abscopal effect.
Wilfred Ngwa, Omoruyi Credit Irabor, +3 authors, Silvia C Formenti.
Nat Rev Cancer, 2018 Feb 17; 18(5). PMID: 29449659    Free PMC article.
Highly Cited. Review.
Antitumor in situ vaccination effect of TNFα and IL-12 plasmid DNA electrotransfer in a murine melanoma model.
Urska Kamensek, Maja Cemazar, +2 authors, Gregor Sersa.
Cancer Immunol Immunother, 2018 Feb 23; 67(5). PMID: 29468364    Free PMC article.
Induction of necrotic cell death and activation of STING in the tumor microenvironment via cationic silica nanoparticles leading to enhanced antitumor immunity.
Myunggi An, Chunsong Yu, +4 authors, Haipeng Liu.
Nanoscale, 2018 May 09; 10(19). PMID: 29737353    Free PMC article.
Tune Up In Situ Autovaccination against Solid Tumors with Oncolytic Viruses.
Teresa Nguyen, Naze G Avci, +2 authors, Hong Jiang.
Cancers (Basel), 2018 Jun 03; 10(6). PMID: 29857493    Free PMC article.
Review.
Slow-Release Formulation of Cowpea Mosaic Virus for In Situ Vaccine Delivery to Treat Ovarian Cancer.
Anna E Czapar, Brylee David B Tiu, +2 authors, Nicole F Steinmetz.
Adv Sci (Weinh), 2018 Jun 08; 5(5). PMID: 29876220    Free PMC article.
Editorial: Local Immunotherapy: A Way to Convert Tumors From "Cold" to "Hot".
Marijo Bilusic, James L Gulley.
J Natl Cancer Inst, 2018 Jul 28; 109(12). PMID: 30053078    Free PMC article.
White paper on microbial anti-cancer therapy and prevention.
Neil S Forbes, Robert S Coffin, +20 authors, Grant McFadden.
J Immunother Cancer, 2018 Aug 08; 6(1). PMID: 30081947    Free PMC article.
Review.
Immunomodulatory Drugs Encoded by Oncolytic Viruses: Is the Whole Greater Than the Sum?
Dmitriy Zamarin.
Mol Ther, 2019 Oct 07; 27(11). PMID: 31586519    Free PMC article.
An inhalable nanoparticulate STING agonist synergizes with radiotherapy to confer long-term control of lung metastases.
Yang Liu, William N Crowe, +4 authors, Dawen Zhao.
Nat Commun, 2019 Nov 11; 10(1). PMID: 31704921    Free PMC article.
Cancer immunotherapy with immunoadjuvants, nanoparticles, and checkpoint inhibitors: Recent progress and challenges in treatment and tracking response to immunotherapy.
Michael-Joseph Gorbet, Ashish Ranjan.
Pharmacol Ther, 2019 Dec 22; 207. PMID: 31863820    Free PMC article.
Review.
The abscopal effect 67 years later: from a side story to center stage.
Sandra Demaria, Silvia C Formenti.
Br J Radiol, 2020 Feb 27; 93(1109). PMID: 32101479    Free PMC article.
Review.
Opportunities for Conventional and in Situ Cancer Vaccine Strategies and Combination with Immunotherapy for Gastrointestinal Cancers, A Review.
Rachid Bouzid, Maikel Peppelenbosch, Sonja I Buschow.
Cancers (Basel), 2020 May 06; 12(5). PMID: 32365838    Free PMC article.
Review.
RIG-1-Like Receptor Activation Synergizes With Intratumoral Alpha Radiation to Induce Pancreatic Tumor Rejection, Triple-Negative Breast Metastases Clearance, and Antitumor Immune Memory in Mice.
Vered Domankevich, Margalit Efrati, +9 authors, Yona Keisari.
Front Oncol, 2020 Aug 09; 10. PMID: 32766128    Free PMC article.
The Promise of Combining Radiation Therapy With Immunotherapy.
Justin C Jagodinsky, Paul M Harari, Zachary S Morris.
Int J Radiat Oncol Biol Phys, 2020 Apr 27; 108(1). PMID: 32335187    Free PMC article.
Review.
Administration of low-dose combination anti-CTLA4, anti-CD137, and anti-OX40 into murine tumor or proximal to the tumor draining lymph node induces systemic tumor regression.
Jonathan P O Hebb, Adriane R Mosley, +4 authors, Dean W Felsher.
Cancer Immunol Immunother, 2017 Sep 15; 67(1). PMID: 28905118    Free PMC article.
Characterization of abscopal effects of intratumoral electroporation-mediated IL-12 gene therapy.
Anandaroop Mukhopadhyay, Jocelyn Wright, +5 authors, Robert H Pierce.
Gene Ther, 2018 Oct 17; 26(1-2). PMID: 30323352    Free PMC article.
Cowpea Mosaic Virus Promotes Anti-Tumor Activity and Immune Memory in a Mouse Ovarian Tumor Model.
Chao Wang, Steven N Fiering, Nicole F Steinmetz.
Adv Ther (Weinh), 2019 May 01; 2(5). PMID: 33969181    Free PMC article.
Irreversible electroporation augments checkpoint immunotherapy in prostate cancer and promotes tumor antigen-specific tissue-resident memory CD8+ T cells.
Brandon J Burbach, Stephen D O'Flanagan, +11 authors, Yoji Shimizu.
Nat Commun, 2021 Jun 25; 12(1). PMID: 34162858    Free PMC article.
Prognostic value of immune factors in the tumor microenvironment of patients with pancreatic ductal adenocarcinoma.
Sachie Kiryu, Zensho Ito, +14 authors, Shigeo Koido.
BMC Cancer, 2021 Nov 12; 21(1). PMID: 34758773    Free PMC article.
Radiation Augments the Local Anti-Tumor Effect of In Situ Vaccine With CpG-Oligodeoxynucleotides and Anti-OX40 in Immunologically Cold Tumor Models.
Alexander A Pieper, Luke M Zangl, +17 authors, Zachary S Morris.
Front Immunol, 2021 Dec 07; 12. PMID: 34868010    Free PMC article.
Theoretical premises of a "three in one" therapeutic approach to treat immunogenic and nonimmunogenic cancers: a narrative review.
Anastasia S Proskurina, Vera S Ruzanova, +2 authors, Sergey S Bogachev.
Transl Cancer Res, 2022 Feb 05; 10(11). PMID: 35116346    Free PMC article.
Review.